Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea-Reference-Cited by-同舟云学术

Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea

Published:2017-04 Issue:8 Volume:119 Page:1205-1210
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Liu Alice,Abbasi Fahim,Kim Sun H.,Ariel Danit,Lamendola Cindy,Cardell James,Xu Shiming,Patel Shailja,Tomasso Vanessa,Mojaddidi Hafasa,Grove Kaylene,Tsao Philip S.,Kushida Clete A.,Reaven Gerald M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Disorders of glucose metabolism in sleep apnea;Punjabi;J Appl Physiol (1985),2005

2. Sleep disturbances and insulin resistance;Van Cauter;Diabet Med,2011

3. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance;Van Cauter;Diabetes,1992

4. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome;Drager;J Am Coll Cardiol,2013

5. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on sleep Disorders Research and the National Heart, Lung, and Blood Institute;Quan;Circulation,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physical health status in first-degree relatives of patients with bipolar disorder, a systematic review;Nordic Journal of Psychiatry;2021-11-11

2. Obstructive Sleep Apnea and Metabolic Risk: an Update;Current Sleep Medicine Reports;2018-04-21